In 2023, Australia became the first country in the world to allow health-care professionals to use a psychedelic drug to ...
Many people have interpreted as a setback the “no” vote by an advisory committee to the Food and Drug Administration on Lykos Therapeutics’ new drug application for MDMA-assisted psychotherapy for ...
First came the rejection, and then came the retractions. On Friday, in a decision that would have been stunning just six months ago, the Food and Drug Administration decided against approving ...
Last month, the first psychedelic therapy treatment came before the Food and Drug Administration for a vote. It entailed using MDMA, also known as ecstasy or molly, to treat PTSD. MDMA therapy has ...
When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...
This article was updated at 535p ET with results of the second vote. A panel of advisors to the U.S. FDA declined to endorse Lykos Therapeutics' application to market psychedelic drug MDMA, also known ...
Untreated mental health concerns remain devastating for our nation, and there is an ongoing need for expanded options and access. In the past few years, there has been a resurgence in interest in ...
In a decision that shocked some observers, key advisers to the US Food and Drug Administration (FDA) voted that the effectiveness of the party drug MDMA for treating post-traumatic stress disorder is ...
My life was forever changed on August 6, 2011, when insurgents shot down a Chinook transport helicopter in Afghanistan, killing all 31 people on board. My husband served in the Navy for 20 years, ...
Add Yahoo as a preferred source to see more of our stories on Google. The research that the FDA considered was spearheaded by the Multidisciplinary Association for Psychedelic Studies (MAPS), which ...
Share on Pinterest A key FDA panel voted down approving MDMA-assisted therapy to treat PTSD. pixdeluxe/Getty Images An expert panel of the Food and Drug Administration reviewed two studies on ...